What is the Impact Factor of Therapeutic Advances in Urology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Advances in Urology is 3.50, ranking in quartile Q1 of Web of Science (SCIE).

Is Therapeutic Advances in Urology indexed in Web of Science or Scopus?

Yes, Therapeutic Advances in Urology is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.111 (Q1) and an H-index of 48.

Who publishes Therapeutic Advances in Urology and what is the Article Processing Charge (APC)?

Therapeutic Advances in Urology is published by SAGE. The estimated Article Processing Charge (APC) is approximately $3,210 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Advances in Urology?

The official ISO-4 abbreviation of Therapeutic Advances in Urology is "THER ADV UROL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #4,110Gold OA

Therapeutic Advances in Urology

Abbreviation (ISO):THER ADV UROL

•

Identifier (ISSN):1756-2872(Print)/1756-2880(Online)

•

Publisher:SAGE

Official Website Submission Portal Compare

Clarivate IF (2026)

3.5– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Therapeutic Advances in Urology

WoS Q1

Annual Impact Factor Metric

Current (2026):3.5

Scopus SJR & RankScopus Q1

1.111

#4,110

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

48 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate3.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

51articles/year

100% Gold OA•51.22% Original Research

Aims & Scope

Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.

Topics Covered (Recognized by AI)

MedicineInternal medicine88.9%Biology86.9%Genetics68.3%Surgery65.5%Pathology64%Cancer53.3%Urology42.6%Endocrinology41.3%Anatomy35.8%Radiology34%Prostate29.1%Psychology28.3%Chemistry28.1%Oncology28.1%Prostate cancer25.7%Biochemistry24.6%Mathematics21.8%Psychiatry20.5%Urinary system20.1%

Primary Research Areas

Medicine Urology

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

UROLOGY & NEPHROLOGY

Rank31/134

IndexSCIE

JCISCIE2026

UROLOGY & NEPHROLOGY

Rank50/134

IndexSCIE

Category	Index	Rank	Quartile
UROLOGY & NEPHROLOGY	JCRSCIE	31/134	Q1
UROLOGY & NEPHROLOGY	JCISCIE	50/134	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.5

Articles / Year57

Total Citations22

2025

IF3.5

Articles / Year49

Total Citations149

2024

IF2.6

Articles / Year41

Total Citations251

2023

IF2

Articles / Year50

Total Citations625

2022

IF3.13

Articles / Year45

Total Citations719

Year	Impact Factor	Articles / Year	Total Citations
2026	3.5	57	22
2025	3.5	49	149
2024	2.6	41	251
2023	2	50	625
2022	3.13	45	719
2021	2.357	56	623
2020	1.918	34	566
2019	—	68	2,224
2018	—	38	986
2017	—	34	623
2016	—	29	897
2015	—	42	1,826

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,110Scopus Q1SCImago Profile

Scopus Coverage:2009-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.111

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.41

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,210 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations500

3-Year Documents132

Citable Documents128

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate25.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

UrologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

2区UROLOGY & NEPHROLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Urology (abbr: THER ADV UROL, ISSN: 1756-2872) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE in England. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.111 (Q1), an H-index of 48.

The journal enforces rigorous peer evaluation with an annual output of approximately 51 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,210 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.